| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,975 |
3,219 |
$385K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,081 |
827 |
$97K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
124 |
74 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
32 |
29 |
$4K |
| 90688 |
|
13 |
13 |
$519.24 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
966 |
753 |
$228.77 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
427 |
344 |
$142.15 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
24 |
$129.81 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
818 |
591 |
$114.46 |
| 36415 |
Collection of venous blood by venipuncture |
664 |
561 |
$25.50 |
| 99173 |
|
71 |
65 |
$0.00 |
| 80061 |
Lipid panel |
13 |
12 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
51 |
48 |
$0.00 |
| 3008F |
|
813 |
668 |
$0.00 |
| 92551 |
|
75 |
65 |
$0.00 |
| 85018 |
|
66 |
59 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
171 |
139 |
$0.00 |
| 96127 |
|
30 |
27 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
15 |
12 |
$0.00 |